Anti-Fas antibodies cross-link with Fas/APO-1, causing apoptosis in human glioma cell lines, suggesting that Fas/APO-1 mediated death could be a promising immunotherapeutic treatment for malignant glioma. This evidence concerns the gene FAS and malignant glioma.